APA (7th ed.) Citation

Tarawneh, R., D'Angelo, G., Crimmins, D., Herries, E., Griest, T., Fagan, A. M., . . . Holtzman, D. M. (2016). Diagnostic and Prognostic Utility of the Synaptic Marker Neurogranin in Alzheimer Disease. JAMA neurology, 73(5), 561. https://doi.org/10.1001/jamaneurol.2016.0086

Chicago Style (17th ed.) Citation

Tarawneh, Rawan, et al. "Diagnostic and Prognostic Utility of the Synaptic Marker Neurogranin in Alzheimer Disease." JAMA Neurology 73, no. 5 (2016): 561. https://doi.org/10.1001/jamaneurol.2016.0086.

MLA (9th ed.) Citation

Tarawneh, Rawan, et al. "Diagnostic and Prognostic Utility of the Synaptic Marker Neurogranin in Alzheimer Disease." JAMA Neurology, vol. 73, no. 5, 2016, p. 561, https://doi.org/10.1001/jamaneurol.2016.0086.